Urology

Urologists discuss emerging therapies, such as focal therapies, that may help improve treatment options for prostate cancer.

Oncologists discuss how patients must balance treatment benefit and quality-of life-considerations in choosing the optimal approach to their prostate cancer.

Prostate cancer is often asymptomatic at the time of diagnosis, and treatment can affect quality of life more than the disease itself does. In this series, specialists discuss treatment benefit vs risk.

Cedars-Sinai experts discuss lifestyle factors in nonmetastatic castration-resistant prostate cancer and prospects for next-generation imaging to detect micrometastases.

Cedars-Sinai oncologists examine the effect of next-generation androgen receptor inhibitors on nonmetastatic castration-resistant prostate cancer management.